Giant Gastric Gastrointestinal Stromal Tumor (GIST)

被引：7

作者：

Navarrete, Andres ^{[1
,2
,3
]}

Momblan, Dulce ^{[1
]}

Almenara, Raul ^{[1
]}

Lacy, Antonio ^{[1
]}

机构：

[1] Hosp Clin Barcelona, Gastrointestinal Surg Dept, Barcelona, Spain

[2] Univ Desarrollo, Fac Med Clin Alemana, Dept Surg, Santiago, Chile

[3] Hosp Mil, Dept Digest Surg, Santiago, Chile

来源：

JOURNAL OF GASTROINTESTINAL SURGERY | 2017年 / 21卷 / 01期

关键词：

GIST; Gastric; Imatinib;

D O I：

10.1007/s11605-016-3196-x

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Gastrointestinal stromal tumors (GIST) represent 0.1-3 % of gastrointestinal malignancy. Surgery is the mainstay of treatment, but in high-risk tumors, imatinib can help to achieve better oncological outcomes. We present a rare case of a patient with gastric GIST with very aggressive evolution in a short period of time despite the use of neoadjuvant therapy with imatinib.

引用

页码：202 / 204

页数：3

共 3 条

[1] Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor. [J].

Joensuu, H ;

Roberts, PJ ;

Sarlomo-Rikala, M ;

Andersson, LC ;

Tervahartiala, P ;

Tuveson, D ;

Silberman, SL ;

Capdeville, R ;

Dimitrijevic, S ;

Druker, B ;

Demetri, GD .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14) :1052-1056

[2] Gastrointestinal stromal tumors of the stomach - A clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up [J].

Miettinen, M ;

Sobin, LH ;

Lasota, J .

AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2005, 29 (01) :52-68

[3] Neoadjuvant and adjuvant imatinib treatment in gastrointestinal stromal tumor: current status and recent developments [J].

Reynoso, David ;

Trent, Jonathan C. .

CURRENT OPINION IN ONCOLOGY, 2010, 22 (04) :330-335

← 1 →